Paul R Edick Insider Trading $XERS XERIS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul R Edick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul R Edick. Paul R Edick is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in NEWLINK GENETICS CORP ($NLNK) and See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Director in Neos Therapeutics, Inc. ($NEOS) and Director in Iterum Therapeutics plc ($ITRM).
Paul R Edick in XERIS PHARMACEUTICALS INC
Trading Symbol: XERSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: See Remarks
Holdings: 636,134 shares
Latest Transaction: Feb 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul R Edick in XERIS PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | A | 5.08 | 400,000 | 2,032,000 | 400,000 | |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 225,000 | 0 | 636,134 | 411.1 K to 636.1 K (+54.73 %) |
Dec 10 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.06 | 10,000 | 40,551 | 411,134 | 401.1 K to 411.1 K (+2.49 %) |
Dec 10 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.06 | 10,000 | 40,551 | 411,134 | 401.1 K to 411.1 K (+2.49 %) |
May 11 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 3.00 | 33,000 | 99,000 | 401,134 | 368.1 K to 401.1 K (+8.96 %) |
Mar 02 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 185,000 | 0 | 368,134 | 183.1 K to 368.1 K (+101.02 %) |
Mar 02 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 185,000 | 0 | 368,134 | 183.1 K to 368.1 K (+101.02 %) |
Feb 18 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.15 | 20,000 | 83,000 | 183,134 | 163.1 K to 183.1 K (+12.26 %) |
Feb 04 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Payment of Exercise | F | 6.37 | 9,801 | 62,432 | 163,134 | 172.9 K to 163.1 K (-5.67 %) |
Nov 27 2019 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 8.55 | 17,935 | 153,283 | 172,935 | 155 K to 172.9 K (+11.57 %) |
Nov 27 2019 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 8.55 | 17,935 | 153,283 | 172,935 | 155 K to 172.9 K (+11.57 %) |
Mar 12 2019 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 9.12 | 30,000 | 273,585 | 155,000 | 125 K to 155 K (+24.00 %) |
Feb 01 2019 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | A | 13.88 | 200,000 | 2,776,000 | 200,000 | |
Feb 01 2019 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | C | 0.00 | 23,922 | 0 | 0 | |
Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | C | 0.00 | 23,922 | 0 | 0 | |
Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | C | 0.00 | 13,430 | 0 | 13,430 | 0 to 13.4 K |
Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | C | 0.00 | 13,430 | 0 | 13,430 | 0 to 13.4 K |
Page: 1